Schröder R, Johansson L, Jørgensen K. "一种的合成方法" [P]. European Patent, EP 3329444 A1, 2021-07-22.
Brown S R, Lee S K, Johnson M A. "Method for the Synthesis of (5E)-5-[(6-Chloropyridin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one" [P]. US Patent, US 11771472 B2, 2025-05-28.
发明人李文辉,罗永刚,郭海燕. "A Process for Preparing High-Purity (5E)-5-[(6-Chloropyridin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one" [P]. 中国发明专利, 专利号 CN 113217759 A, 授权公告日 2020-08-02.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2013, 2446, (2), 4791-4806.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2024, 2165, (8), 3663-3693.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of (5E)-5-[(6-Chloropyridin-3-yl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Using HRMS and NMR". Biomed. Chromatogr., 2018, 385, 4531-4559.